PARP1 and familial pancreatic carcinoma: Through co-immunoprecipitation, we observed an interaction between PARP1 and TOPBP1 in pancreatic cancer cell lines, indicating the involvement of complex molecular regulatory mechanisms in the combined effects of olaparib with shTOPBP1 or ATRi.